Medical Devices Startups
5,181 companies tagged Medical Devices, with their investors and founders.
Standard Bariatrics develops the Titan SGS™ Stapler, a specialized surgical device designed for sleeve gastrectomy procedures that creates consistent and symmetrical gastric pouches using an anatomy-based approach.
7 investors
Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.
7 investors
Tessera Therapeutics develops Gene Writing, a genome engineering technology platform designed to make permanent alterations to the human genome for treating diseases. The company focuses on non-viral delivery methods to enable potentially curative genetic therapies.
7 investors
Transmutex develops accelerator-powered technology that converts nuclear waste into clean energy and produces medical radioisotopes. The company serves energy providers, waste management operators, and healthcare providers across the nuclear energy, waste management, and medical sectors.
7 investors
Trexo develops a robotic device that enables children with cerebral palsy and other mobility disabilities to walk independently at home. The device is designed for use by children, parents, and physiotherapists, combining therapeutic function with home accessibility.
7 investors
U.S. Renal Care provides kidney care and dialysis services for people living with kidney disease, operating over 500 dialysis centers and 200+ home programs across 32 U.S. states. The organization also provides administrative services to Satellite Healthcare Inc.
7 investors
Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.
7 investors
VeriSIM uses machine learning and computational simulation to accelerate drug development, replacing traditional trial-and-error experimentation with computational prediction to improve success rates and reduce animal testing. The company serves pharmaceutical partners and research institutions developing new medicines.
7 investors
Verse Medical builds software to coordinate home-based healthcare services, replacing fragmented vendor interactions and outdated communication methods with a unified platform for in-home care providers.
7 investors
Visby Medical manufactures at-home PCR tests for sexually transmitted infections, providing FDA-authorized results in 30 minutes. The company serves individuals seeking fast, private STI testing without clinical delays, with integrated telehealth access for positive results.
7 investors
Vistapath develops technology solutions to modernize pathology lab operations, helping pathology laboratories improve quality, efficiency, and consistency in critical lab processes.
7 investors
WavelyDx offers an FDA-listed acoustic scanning device and companion smartphone app that lets parents check their child's ears at home for signs of an ear infection. It uses sound waves bounced off the eardrum to detect fluid and provide a likely/unlikely result, with access to partnered virtual doctors for consults.
7 investors
Abivax develops obefazimod, an orally administered small molecule drug candidate with a novel mechanism of action targeting microRNA biology to treat chronic inflammatory diseases including ulcerative colitis and Crohn's disease.
6 investors
A pharmaceutical company that develops medicines and vaccines for patients globally.
6 investors
Aclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases. The company's clinical and preclinical pipeline includes candidates in development for severe asthma, atopic dermatitis, and T-cell-mediated autoimmune conditions.
6 investors
Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases. The company combines next-generation RNA therapeutics, brain delivery technologies, and biomarker-guided precision medicine to silence disease-causing genes in the brain.
6 investors
Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need. Its product candidates target established biological pathways using organ-restricted approaches to resolve fibro-inflammation and restore organ function.
6 investors
AIQ Solutions develops TRAQinform IQ, a software medical device that analyzes serial radiographic images (such as PET and CT scans) to quantify changes in individual tumor lesions over time. The cloud-based, HIPAA-compliant tool generates reports that oncologists and clinicians use to adjust therapies and optimize late-stage cancer treatment.
6 investors
Alerje develops FAIT, a mobile app and clinical platform for food allergy oral immunotherapy (OIT), offering dose tracking, HIPAA-compliant clinic messaging, and predictive insights. It serves families managing childhood food allergies and the allergy clinics coordinating their care.
6 investors
Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling. It serves pharmaceutical and life-science researchers as an alternative to animal studies and Caco-2 cell lines, offering ready-to-use kits and custom studies.
6 investors
Aluna develops a portable respiratory management tool for children with asthma and other chronic respiratory diseases. The device gathers daily health data and transmits it in real time to parents and healthcare providers.
6 investors
AppliedVR develops immersive therapeutic software using technology to deliver drug-free clinical treatments for patients. The company focuses on healthcare applications where traditional medical approaches have limitations.
6 investors
Arsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors. The company uses computational and engineering approaches to create cancer medicines.
6 investors
Ascendis Pharma is a biopharmaceutical company developing therapies for hormone-related disorders and rare diseases. The company focuses on long-acting therapeutic formulations to address endocrine and rare disease indications.
6 investors